Pathogenomix

Pathogenomix Advanced sequencing analysis with Pathogenomix RipSeq online easy-to-use software. Any sequence, no All you need is an internet browser.

Infection Intelligence

RipSeq sequence-based analysis reduces the time needed to identify infectious pathogens, in pure- or poly-microbial samples, by up to 90% - and provides answers where other methods fail. Use any sequencing technology you want - Ripseq is platform agnostic. Combined with Ripseq DB, this is complete SaaS diagnostic solution, able to identify pathogens more accurately, faster

and at lower cost than current methods. Platform agnostic

RipSeq can analyze both NGS & Sanger direct-from-speciment sequencing files. Using our novel algorithms, the total time for one analysis is less than five minutes - no matter if the sample is a pure sample or a poly microbial one. Curated databases

Our Ripseq DB databases has the most up to date references, but without the clutter. Databases are filtered and automatically curated to ensure an ID you can rely on. Cloud SaaS solution

RipSeq is always online and always updated. We push our new algorithms as well as new database references up to the cloud every night for your benefit.

Santa Cruz, CA: January 19th 2022 – Pathogenomix Inc., a Next Generation Sequencing, pathogen diagnostic company, announ...
01/19/2022

Santa Cruz, CA: January 19th 2022 – Pathogenomix Inc., a Next Generation Sequencing, pathogen diagnostic company, announced that the US Food and Drug Administration (FDA) has granted it a Breakthrough Device Designation for its Patho-Seq assay.

https://pathogenomix.com/pathogenomix_newsroom.aspx

Great, new articles on Sanger use in the clinical lab!
04/30/2021

Great, new articles on Sanger use in the clinical lab!

Great new articles on the use of NGS in clinical infections.
04/29/2021

Great new articles on the use of NGS in clinical infections.

Great article from Mayo Clinic showing the potential for using a broad-range bacterial detection approach for diagnosis ...
03/01/2021

Great article from Mayo Clinic showing the potential for using a broad-range bacterial detection approach for diagnosis of tick-borne bacterial infection from blood. Our Ripseq NGS performed great! Time to give it a try?

https://jcm.asm.org/content/early/2021/02/19/JCM.03129-20

Great article on the risk of secondary infections during the pandemic. Correct pathogen ID is crucial.
06/11/2020

Great article on the risk of secondary infections during the pandemic. Correct pathogen ID is crucial.

Separating the signal from the noise

Wuhan, China patients pre Jan 31st 2020: "Half of non-survivors experienced a secondary infection":
03/26/2020

Wuhan, China patients pre Jan 31st 2020: "Half of non-survivors experienced a secondary infection":

The potential risk factors of older age, high SOFA score, and d-dimer greater than 1 μg/mL could help clinicians to identify patients with poor prognosis at an early stage. Prolonged viral shedding provides the rationale for a strategy of isolation of infected patients and optimal antiviral interve...

07/22/2019

Check out our latest articles on pathogen ID in the clinic. 14 days trial + hands-on demo for free!

Rapid Direct Sequencing Analysis of Clinical Samples using NGS or Sanger. Less than 5 minutes analysis time. No bioinformatics resources needed.

Address

499 Lake Avenue
Santa Cruz, CA
95062

Alerts

Be the first to know and let us send you an email when Pathogenomix posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share